Medical Weight Loss & GLP-1 Therapy in Westfield, NJ
Endocrinologist-led weight care, in person or by telehealth in NJ, NY & FL
EndoHealth MD offers medical weight loss led by Dr. Alessia Roehnelt, a double board-certified endocrinologist. Care includes a full metabolic evaluation, injectable and oral GLP-1 medications such as Wegovy, Zepbound, and Foundayo when appropriate, and body composition tracking to protect muscle while you lose fat.
Weight is not only about willpower. Hormones, insulin resistance, thyroid function, sleep, and stage of life all play a part. We find out what is driving your weight before choosing a treatment.
Schedule a consultation to find out which approach fits you.
Is This Right for You?
Common reasons patients come to us
You may be a good fit if you have gained weight during perimenopause or menopause without changing your habits, if you have insulin resistance or prediabetes, or if you tried a GLP-1 through an app or med spa and stalled, had side effects, or regained the weight.
​
This is not a prescription-only service. Medication is one tool inside a complete medical plan, with a physician monitoring your labs, your muscle, and how you feel.
How We Evaluate Your Metabolism
A full picture before any prescription
Care begins with a 60-minute consultation with Dr. Roehnelt. She reviews your history, medications, and past labs, then orders any testing you need. This may include thyroid function, fasting insulin and glucose, A1c, and cholesterol.
​
An InBody scan measures your muscle, body fat, and visceral fat. This gives us a starting point, so we can see what you are losing as the scale changes.
GLP-1 Medications and Other Options
Matched to your health, not a one-size plan
GLP-1 medications lower appetite and improve blood sugar control. Semaglutide (Wegovy) and tirzepatide (Zepbound) are FDA-approved for chronic weight management. Ozempic and Mounjaro contain the same ingredients and are approved for type 2 diabetes. In a head-to-head trial, people taking tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared with 13.7% for semaglutide.
​
There are now pill options as well. The Wegovy pill (oral semaglutide) was approved for weight management in December 2025, and Foundayo (orforglipron) was approved in April 2026. Foundayo is taken once a day, at any time, with or without food. In its main trial, people on the highest dose lost an average of 12.4% of their body weight over 72 weeks. Pills avoid injections, but in separate trials the average weight loss was lower than with injectable tirzepatide. The right choice depends on your goals, your health history, and what you will take consistently.
Not everyone needs or wants medication. Your plan may also include nutrition, strength training, sleep, and treatment of thyroid or hormone problems. Dr. Roehnelt reviews the benefits, the side effects, and who should not take these medications.
​
Sources: FDA, Wegovy approval (2021); FDA, Zepbound approval (2023); Aronne et al., New England Journal of Medicine (2025); FDA, Foundayo approval (2026).
Protecting Muscle While You Lose Weight
The scale does not tell the whole story
Fast weight loss can take muscle along with fat. We repeat your InBody scan over time, set protein and strength-training goals, and adjust your dose so the weight you lose is mostly fat.
​
We also plan for the long term, including how to maintain your results and what to expect if you stop medication.
Common Questions
Short answers to what patients ask most
Do you prescribe GLP-1 medications? Yes, when they are medically appropriate after a full evaluation.
​
Are there pill options instead of injections? Yes. The Wegovy pill and Foundayo are both FDA-approved oral GLP-1 medications. Dr. Roehnelt will review whether a pill or an injection is the better fit for you.
​
I tried a GLP-1 and it did not work. Can you help? Often, yes. Dose, side effects, muscle loss, and untreated hormone or metabolic problems are common reasons for a stall, and each can be addressed.
​
Will insurance cover my medication? EndoHealth MD does not bill insurance for visits. Your prescription may still be covered by your plan, and we help with prior authorizations.
​
Can I do this by telehealth? Yes. Dr. Roehnelt sees patients virtually in New Jersey, New York, and Florida
Ready to Take the Next Step?
Begin with a new patient consultation. Ongoing care is provided through our membership.
Medically reviewed by Alessia Roehnelt, MD. Last reviewed October 2026.
Location & Telehealth
-
In-person Care: 189 Elm Street, Lower Level, Westfield, NJ 973-559-2933
-
Virtual Care: NJ, NY, and FL
Insurance & Medicare Notice
EndoHealth MD is a direct-pay practice and does not bill insurance.
We provide superbills you may submit for possible out-of-network reimbursement.
Dr. Roehnelt has opted out of Medicare; services cannot be submitted to Medicare for reimbursement.